• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与新型冠状病毒2型感染相关的神经系统并发症:单中心经验

Neurological Complications Associated With SARS-CoV-2 Infection: A Single-Centre Experience.

作者信息

Martins Mariana, Pereira Ana, Teixeira André, Lima Diana, Lopes Nuno, Amaral-Silva Marta, Seixo Isabel, Miguéns Ana Catarina

机构信息

Physical Medicine and Rehabilitation, Centro Hospitalar Universitário de Lisboa Central, Lisbon, PRT.

出版信息

Cureus. 2022 Dec 18;14(12):e32655. doi: 10.7759/cureus.32655. eCollection 2022 Dec.

DOI:10.7759/cureus.32655
PMID:36654564
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9844021/
Abstract

BACKGROUND

The clinical presentation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can range from mild or moderate disease (80% of the cases) to severe disease (15%) requiring oxygen support, and critical disease (5%), associated with acute respiratory distress syndrome and admission to the intensive care unit (ICU). In critically ill patients, prone positioning can be used to optimize oxygenation. Although there is a favourable response to this strategy, being a life-saving measure, additional associated complications may appear, including compressive neuropathies. Despite respiratory affection being more common, SARS-CoV-2 infection can also attack other systems and can, under certain conditions, affect the central or peripheral nervous system. It has been described that neurological manifestations can result from the neuroinvasive properties of the SARS-CoV-2 or as an indirect consequence of multiorgan dysfunction.

AIMS

We intend to report the patients who presented with neurological complications associated with coronavirus disease 2019 (COVID-19) and/or complications of its treatment, followed in our physical and rehabilitation medicine (PRM) service.

MATERIALS AND METHODS

A retrospective analysis of patients admitted to the PRM ward with outpatient consultation in the context of post-COVID-19 status between April 2020 and November 2021 (the period of the highest prevalence of infection) was carried out. Patients with neurological complications after SARS-CoV-2 infection and consequently a decline in previous functionality were identified.

RESULTS

Thirteen patients (23.6%) admitted to the PRM ward had peripheral neurological complications, documented by electroneuromyography, including Guillain-Barré syndrome, sensory-motor polyneuropathy, peroneal nerve injury, femoral nerve injury, and lumbar plexus injury. The neurological complications of the patients followed in a post-COVID-19 consultation were also evaluated. Eight patients (20%) reported neurological sequelae. Five patients presented peripheral nerve damage (peroneal, accessory, ulnar, and recurrent laryngeal) of undefined aetiology, diagnosed after the acute phase of hospitalization. Two patients had COVID-19 infection followed by ischemic stroke (vertebrobasilar and middle cerebral artery), requiring hospitalization in the acute phase. One patient had COVID-19 infection followed by longitudinal myelitis, with positive anti-myelin oligodendrocyte glycoprotein (MOG). All patients required follow-up by the rehabilitation team with partial recovery of deficits.

CONCLUSIONS

All patients admitted to the PRM ward with neurological manifestations had critical disease and symptoms compatible with peripheral nervous system involvement. Patients admitted to the PRM consultation had different levels of viral disease severity and had sequelae related to peripheral and central nervous system disorders. Identifying the aetiology of these injuries is essential for us to act on their prevention, particularly with regard to indirect complications, such as compressive neuropathies. It will be necessary to maintain the follow-up of these patients to understand the evolution of the neurological consequences associated with COVID-19.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eee7/9844021/a820fc93c644/cureus-0014-00000032655-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eee7/9844021/a820fc93c644/cureus-0014-00000032655-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eee7/9844021/a820fc93c644/cureus-0014-00000032655-i01.jpg
摘要

背景

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染的临床表现范围广泛,从轻症或中症疾病(80%的病例)到需要氧疗的重症疾病(15%)以及危重症疾病(5%),后者与急性呼吸窘迫综合征和入住重症监护病房(ICU)相关。在危重症患者中,俯卧位可用于优化氧合。尽管该策略有良好效果,是一种挽救生命的措施,但可能会出现其他相关并发症,包括压迫性神经病变。尽管呼吸道受累更为常见,但SARS-CoV-2感染也可侵袭其他系统,在某些情况下,还会影响中枢或周围神经系统。据描述,神经表现可能源于SARS-CoV-2的神经侵袭特性,或是多器官功能障碍的间接后果。

目的

我们打算报告在我们的物理医学与康复医学(PRM)科室就诊的、出现与2019冠状病毒病(COVID-19)相关的神经并发症和/或其治疗并发症的患者情况。

材料与方法

对2020年4月至2021年11月(感染流行率最高的时期)在PRM病房因COVID-19后状态进行门诊咨询而入院的患者进行回顾性分析。确定了SARS-CoV-2感染后出现神经并发症并导致先前功能下降的患者。

结果

入住PRM病房的13名患者(23.6%)存在周围神经并发症,经肌电图记录,包括吉兰-巴雷综合征、感觉运动性多发性神经病、腓总神经损伤、股神经损伤和腰丛损伤。还评估了在COVID-19后咨询中随访的患者的神经并发症。8名患者(20%)报告有神经后遗症。5名患者出现病因不明的周围神经损伤(腓总神经、副神经、尺神经和喉返神经),在住院急性期后确诊。2名患者感染COVID-19后发生缺血性中风(椎基底动脉和大脑中动脉),急性期需要住院治疗。1名患者感染COVID-19后发生纵向脊髓炎,抗髓鞘少突胶质细胞糖蛋白(MOG)呈阳性。所有患者均需康复团队随访,部分功能缺损有所恢复。

结论

入住PRM病房有神经表现的所有患者均患有危重症疾病,症状与周围神经系统受累相符。在PRM咨询中就诊的患者有不同程度的病毒病严重程度,存在与周围和中枢神经系统疾病相关的后遗症。确定这些损伤的病因对于我们采取预防措施至关重要,特别是对于间接并发症,如压迫性神经病变。有必要对这些患者进行随访,以了解与COVID-19相关的神经后果的演变情况。

相似文献

1
Neurological Complications Associated With SARS-CoV-2 Infection: A Single-Centre Experience.与新型冠状病毒2型感染相关的神经系统并发症:单中心经验
Cureus. 2022 Dec 18;14(12):e32655. doi: 10.7759/cureus.32655. eCollection 2022 Dec.
2
Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.重症监护治疗新型冠状病毒 SARS-CoV-2 感染患者:意大利克雷马医院的经验。
Am J Emerg Med. 2021 Jul;45:156-161. doi: 10.1016/j.ajem.2020.08.005. Epub 2020 Aug 16.
3
Optic neuropathies post-Covid 19 - review.新冠病毒感染后视神经病变 - 综述。
Rom J Ophthalmol. 2022 Oct-Dec;66(4):289-298. doi: 10.22336/rjo.2022.54.
4
Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.SARS-CoV-2 的神经入侵、嗜神经性和神经炎症事件:了解 COVID-19 患者的神经表现。
Neurol Sci. 2020 Oct;41(10):2657-2669. doi: 10.1007/s10072-020-04575-3. Epub 2020 Jul 28.
5
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
6
Clinical and Electrophysiological Outcome Measures of Patients With Post-Infectious Neurological Syndromes Related to COVID-19 Treated With Intensive Neurorehabilitation.接受强化神经康复治疗的与COVID-19相关的感染后神经综合征患者的临床和电生理结果指标
Front Neurol. 2021 Mar 12;12:643713. doi: 10.3389/fneur.2021.643713. eCollection 2021.
7
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.评估 BIO101 预防 COVID-19 肺炎患者呼吸恶化的疗效和安全性(COVA 研究):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5.
8
Review of Neurological Manifestations of SARS-CoV-2.新型冠状病毒2019(SARS-CoV-2)神经表现的综述
Cureus. 2023 Apr 27;15(4):e38194. doi: 10.7759/cureus.38194. eCollection 2023 Apr.
9
Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19).与严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)和 2019 冠状病毒病(COVID-19)相关的神经症状、表现和并发症。
J Neurol. 2021 Sep;268(9):3059-3071. doi: 10.1007/s00415-021-10406-y. Epub 2021 Jan 23.
10
Neurological Sequelae of COVID-19.新型冠状病毒肺炎的神经系统后遗症。
J Integr Neurosci. 2022 Apr 6;21(3):77. doi: 10.31083/j.jin2103077.

引用本文的文献

1
Delimiting MOGAD as a disease entity using translational imaging.利用转化成像界定视神经脊髓炎谱系疾病作为一种疾病实体。
Front Neurol. 2023 Dec 7;14:1216477. doi: 10.3389/fneur.2023.1216477. eCollection 2023.

本文引用的文献

1
Hypercoagulability of COVID-19 and Neurological Complications: A Review.COVID-19 的高凝状态与神经系统并发症:综述。
J Stroke Cerebrovasc Dis. 2022 Jan;31(1):106163. doi: 10.1016/j.jstrokecerebrovasdis.2021.106163. Epub 2021 Oct 26.
2
Neurological Complications in COVID-19 Patients With ECMO Support: A Systematic Review and Meta-Analysis.COVID-19 患者在体外膜肺氧合(ECMO)支持下的神经系统并发症:系统评价和荟萃分析。
Heart Lung Circ. 2022 Feb;31(2):292-298. doi: 10.1016/j.hlc.2021.10.007. Epub 2021 Oct 28.
3
The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection.
新型冠状病毒感染后急性后遗症的神经系统表现。
Curr Neurol Neurosci Rep. 2021 Jun 28;21(9):44. doi: 10.1007/s11910-021-01130-1.
4
COVID-19 Proned Ventilation and Its Possible Association With Foot Drop: A Case Series.新型冠状病毒肺炎俯卧位通气及其与足下垂的可能关联:病例系列
Cureus. 2021 Apr 8;13(4):e14374. doi: 10.7759/cureus.14374.
5
Neurological Complications of COVID-19: Underlying Mechanisms and Management.新型冠状病毒肺炎相关神经系统并发症:发病机制与治疗。
Int J Mol Sci. 2021 Apr 15;22(8):4081. doi: 10.3390/ijms22084081.
6
Acute and Post-Acute Neurological Complications of COVID-19.新型冠状病毒肺炎的急性和急性后神经并发症
Neurol Int. 2021 Mar 9;13(1):102-119. doi: 10.3390/neurolint13010010.
7
SARS-CoV-2 mediated neuroinflammation and the impact of COVID-19 in neurological disorders.SARS-CoV-2 介导的神经炎症与 COVID-19 在神经退行性疾病中的作用。
Cytokine Growth Factor Rev. 2021 Apr;58:1-15. doi: 10.1016/j.cytogfr.2021.02.002. Epub 2021 Feb 19.
8
Overview of COVID-19 and neurological complications.COVID-19 概述及神经系统并发症。
Rev Neurosci. 2021 Feb 15;32(6):671-691. doi: 10.1515/revneuro-2020-0116. Print 2021 Aug 26.
9
Spontaneous ilio-psoas haematomas (IPHs): a warning for COVID-19 inpatients.自发性髂腰肌血肿(IPHs):住院 COVID-19 患者的一个警示。
Ann Med. 2021 Dec;53(1):295-301. doi: 10.1080/07853890.2021.1875498.
10
Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.新型冠状病毒(CoV)在神经系统中的发病机制和新兴病原体 SARS-CoV-2 的证据:神经系统损伤和表现的综述。
J Mol Neurosci. 2021 Nov;71(11):2192-2209. doi: 10.1007/s12031-020-01767-6. Epub 2021 Jan 19.